Buianova S N, Feĭzulla M F, Iakovleva N I, Vlasova L I, Potapova T M
Akush Ginekol (Mosk). 1993(5):49-51.
Body defense potential was examined in 156 patients with genital fistulas of inflammatory origin. Addition of myelopid, an immunomodulating agent, to the scheme of preoperative treatment was experimentally validated. Preoperative preparation was assessed from the time course of the patients' general status, blood parameters, liver and kidney functions, and immunity status.
对156例炎性起源的生殖瘘患者的机体防御潜力进行了检查。实验验证了在术前治疗方案中添加免疫调节剂髓过氧化物酶。从患者的一般状况、血液参数、肝肾功能和免疫状态的时间进程评估术前准备情况。
